Coronary risk prediction for those with and without diabetes

European Journal of Preventive Cardiology

Volumn 13, Issue 1, 2006, Pages 30-36

  Woodward, Mark ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

blood pressure; cholesterol; coronary heart disease; diabetes; risk; smoking

Indexed keywords

AGE; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY RISK; DIABETES MELLITUS; FIXED MODEL; HOSMER LEMESHOW STATISTICS; HUMAN; INTERACTION MODEL; ISCHEMIC HEART DISEASE; MATHEMATICAL VARIABLE; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SMOKING; STATISTICAL MODEL; STATISTICS; STEPPED MODEL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ASIA; AUSTRALIA; COHORT STUDIES; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; ROC CURVE; SURVIVAL ANALYSIS;

EID: 33646119404     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000186619.68110.95     Document Type: Article

References (36)

1. Tunstall-Pedoe H. “Absolute” isinappropriate for quantitative risk estimation. BMJ 2000; 320: 723.
2. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for healthprofessionals. Circulation 1991; 83: 356–362.
3. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factorcategories. Circulation 1998; 97: 1837–1847.
4. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: TheFramingham Study risk score. Statist Med 2004; 23: 1631–1660.
5. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R. On behalf of the British Cardiac Society, British HyperlipidaemiaAssociation, British Hypertension Society, and British Diabetic Association.Joint British recommendations on prevention of coronary heart disease inclinical practice. Heart 1999; 80(Suppl2):S1–S29.
6. The Diverse Populations Collaboration. Prediction of mortality from coronary heart disease amongdiverse populations. Is there a common predictivefunction? Heart 2002; 88: 222–228.
7. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8years. Eur Heart J 1998; 19(SupplA):A2–A11.
8. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten year risk of fatalcardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
9. Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus:comparison of UKPDS risk engine with Framingham risk assessment function andits clinical implications. Diabet Med 2004; 21: 238–245.
10. Folsom AR, Chambless LE, Duncan BB, Gilbert AC, Pankrow JS. Prediction of coronary heart disease in middle-aged adults withdiabetes. Diabetes Care 2003; 26: 2777–2784.
11. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non-insulin dependentdiabetes mellitus: United Kingdom prospective diabetes study(UKPDS). BMJ 1998; 316: 823–828.
12. Stephens JW, Ambler G, Vallance P, Betteridge DJ, Humphries SE, Hurel SJ. Cardiovascular risk and diabetes. Are the methods of riskprediction satisfactory? Eur J CardiovascPrev Rehabil 2004; 11: 521–528.
13. Game FL, Bartlett WA, Bayly GR, Jones AF. Comparative accuracy of cardiovascular risk prediction methods inpatients with diabetes mellitus. Diabetes Obes Metab 2001; 3: 279–286.
14. Expert Panel on Detection, Evaluation and Treatment of High BloodCholesterol in Adults. Executive Summary of TheThird Report of The National Cholesterol Education Program (NCEP) ExpertPanel on Detection, Evaluation, And Treatment of High Blood Cholesterol InAdults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint NationalCommitteee on prevention, detection, evaluation and treatment of high bloodpressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
16. Asia Pacific Cohort Studies Collaboration. Determinants of cardiovascular disease in the Asia Pacificregion: protocol for a collaborative overview of cohortstudies. CVD Prevent 1999; 2: 281–289.
17. Asia Pacific Cohort Studies Collaboration. Theeffects of diabetes on the risks of major cardiovascular diseases and deathin the Asia-Pacific region. Diabetes Care 2003; 26: 360–366.
18. Woodward M. Epidemiology: study design and data analysis. 2nd ed. Boca Raton: Chapman andHall/CRC Press; 2005.
19. Asia Pacific Cohort Studies Collaboration. Bloodpressure and cardiovascular disease in the Asia Pacificregion. J Hypertens 2003; 21: 707–716.
20. Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease and stroke in the AsiaPacific region. Int J Epidemiol 2003; 32: 563–572.
21. Asia Pacific Cohort Studies Collaboration. Acomparison of the associations between risk factors and cardiovasculardisease in Asia and Australasia. Eur J CardiovascPrev Rehabil 2005; 12: 484–491.
22. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: JohnWiley; 2000.
23. New Zealand Guidelines Group. Assessment and managementof cardiovascular risk [online resource]. www.nzgg.org.nz.[Accessed 31 May 2005].
24. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. Guidelines for management ofhypertension: report of the fourth working party of the British HypertensionSociety, 2004: BHS IV. J Human Hypertens 2004; 18: 139–185.
25. European Society of Cardiology, European Atherosclerosis Society,European Society of Hypertension, International Society of BehaviouralMedicine, European Society of General Practice/Family Medicine,European Heart Network. Prevention of coronary heartdisease in clinical practice. Recommendations of the Second Joint Task Forceof European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434–1503.
26. Wincour PH, Fisher M. Prediction of cardiovascular risk in people withdiabetes. Diabet Med 2003; 20: 515–527.
27. Game FL, Jones AF. Coronary heart disease risk assessment in diabetes mellitus: acomparison of PROCAM and Framingham risk assessmentfunctions. Diabet Med 2001; 18: 355–359.
28. Asia Pacific Cohort Studies Collaboration. Serumtriglycerides as a risk factor for cardiovascular diseases in the AsiaPacific region. Circulation 2004; 110: 2678–2686.
29. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2diabetes and in nondiabetic subjects with and without prior myocardialinfarction. N Engl J Med 1998; 339: 229–234.
30. Simons LA, Simons J, Engler RL, McGurk C, Harper R, McCance DR, et al. Diabetes and coronary heartdisease. N Engl J Med 1998; 339: 1714–1716.
31. Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G, et al. Cardiovascular events in type 2 diabetes:comparison with nondiabetic individuals without and with priorcardiovascular disease: 10-year follow-up of the HoornStudy. Eur Heart J 2003; 24: 1406–1413.
32. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men withdiabetes and in men with coronary heart disease. Heart 2004; 90: 1398–1403.
33. Lee CD, Folsom AR, Pankow JS, Brancati FL. For the Atherosclerosis Risk in Communities (ARIC) StudyInvestigators. Cardiovascular events in diabetic and nondiabetic adults withor without history of myocardial infarction. Circulation 2004; 109: 855–860.
34. Evans JMM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2diabetes and those who had had a myocardial infarction: cross sectional andcohort studies. BMJ 2002; 324: 939.
35. Whiteley L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease riskequivalent? Results from 25 years of follow-up in the Renfrew andPaisley study. Diabetes Care 2005; 28: 1588–1593.
36. Davis TME, Parsons RW, Broadhurst RJ, Hobbs MST, Jamrozik K. Arrhythmias and mortality after myocardial infarction in diabeticpatients. Diabetes Care 1998; 21: 637–640.